Medical News

RSS

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

BioTime, Inc. today reported financial results for the fourth quarter and fiscal year ended December 31, 2009 and provided an update on recent corporate developments.

10 Mar 2010

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies’ exclusive global agreement to develop and commercialize Hematide™, Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.

10 Mar 2010

$Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures$

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

10 Mar 2010

$Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures$

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

10 Mar 2010

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.

10 Mar 2010

ZixCorp renewes and expandes contract with Wake Forest University Baptist Medical Center

Zix Corporation, the only email encryption service designed with your most important relationships in mind, has renewed and expanded its contract with Wake Forest University Baptist Medical Center, a leading North Carolina health system.

10 Mar 2010

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Smith & Nephew's Endoscopy Division today announced the launch of the BIORAPTOR™ Knotless Suture Anchor, a device used to repair a torn labrum in the hip and shoulder. The anchor is among products featured at the American Academy of Orthopaedic Surgeons annual meeting, which began today in New Orleans.

10 Mar 2010

Labeltronix completes registration to the ISO 9001:2008 standard

Labeltronix, a leading provider of printed labels, labeling systems, supplies and technical support, announces that it has successfully completed registration to the ISO 9001:2008 standard, an internationally recognized protocol for quality assurance.

10 Mar 2010

McGill University's Nurse Practitioner programs to be sponsored by Abbott

Today Abbott Laboratories announced it will sponsor McGill University's Nurse Practitioner programs launched by the McGill School of Nursing of the Faculty of Medicine. Over the last five years, the Nurse Practitioner programs have provided advanced training for registered nurses that enables them to assume additional responsibilities to provide enhanced patient care.

10 Mar 2010

ADHD News Network Broadcast wins Shire and P2M coveted 2010 Telly Award

After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.

10 Mar 2010

TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

Isilon® Systems today announced that The Translational Genomics Research Institute has deployed Isilon scale-out NAS as the primary storage solution powering its next-generation biomedical research. By using Isilon IQ to power multiple genome sequencing devices, TGen has unified its mission-critical operations onto a single, high-performance, highly scalable shared pool of storage, increasing workflow productivity and reducing costs to accelerate the discovery of new treatments for life-threatening diseases.

10 Mar 2010

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma.

10 Mar 2010

OSI Pharmaceuticals deploys Veeva Systems' SaaS CRM application

Veeva Systems announced today that it will support OSI Pharmaceuticals, Inc. with its SaaS Customer Relationship Management (CRM) application, which OSI deployed to its sales team in February after a rapid implementation. OSI selected Veeva CRM® for its ease of use, relevant functionality, and speed.

10 Mar 2010

Astra Tech's OsseoSpeed TX implant line launched to the US market at AO Annual Meeting

Astra Tech, leading provider of comprehensive solutions for dental implant therapy, launched their OsseoSpeed™ TX implant line to the US market at this year’s AO Annual Meeting. The OsseoSpeed™ TX implant comes as the next step in the continuous evolution of the Astra Tech Implant System™ with its modified tapered apex design, first introduced with the launch of their narrow two-piece implant, OsseoSpeed™ TX 3.0 S in June 2008.

10 Mar 2010

Body Bar announces acquisition by Craig Williams

Body Bar® Inc. a premier fitness company specializing in products and educational tools for fitness enthusiasts of all ages and abilities, today announced that Craig Williams has acquired Body Bar Inc., and will join the company as president, effective immediately. All of the current employees will remain with the company.

10 Mar 2010

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2009.

10 Mar 2010

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Abbott announced today it has received U.S. Food and Drug Administration approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.

10 Mar 2010

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.

10 Mar 2010

European countries to review impact of environmental policies on popluation health status

Representatives of 53 Member States from the WHO European Region will gather in Parma, Italy, on 10-12 March 2010 to review the impact of national and cross-border environmental policies on the health status of their populations.

10 Mar 2010

First Edition: March 10, 2010

Protests, million-dollar ad campaigns, deepening partisan fault lines and president's stepped-up health reform end game dominate today's health care headlines.

10 Mar 2010

Medical News

BioTime's fourth-quarter fiscal 2009 total quarterly revenue up 163%

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

ZixCorp renewes and expandes contract with Wake Forest University Baptist Medical Center

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Labeltronix completes registration to the ISO 9001:2008 standard

McGill University's Nurse Practitioner programs to be sponsored by Abbott

ADHD News Network Broadcast wins Shire and P2M coveted 2010 Telly Award

TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

OSI Pharmaceuticals deploys Veeva Systems' SaaS CRM application

Astra Tech's OsseoSpeed TX implant line launched to the US market at AO Annual Meeting

Body Bar announces acquisition by Craig Williams

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

European countries to review impact of environmental policies on popluation health status

First Edition: March 10, 2010

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News